|
1
|
Banwell B, Bennett JL, Marignier R, Kim
HJ, Brilot F, Flanagan EP, Ramanathan S, Waters P, Tenembaum S,
Graves JS, et al: Diagnosis of myelin oligodendrocyte glycoprotein
antibody-associated disease: International MOGAD Panel proposed
criteria. Lancet Neurol. 22:268–282. 2023.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Al-Ani A, Chen JJ and Costello F: Myelin
oligodendrocyte glycoprotein antibody-associated disease (MOGAD):
Current understanding and challenges. J Neurol. 270:4132–4150.
2023.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Häußler V, Trebst C, Engels D, Pellkofer
H, Havla J, Duchow A, Schindler P, Schwake C, Pakeerathan T,
Fischer K, et al: Real-world multicentre cohort study on choices
and effectiveness of immunotherapies in NMOSD and MOGAD. J Neurol
Neurosurg Psychiatry: jnnp-2024-334764, 2024.
|
|
4
|
Silvis SM, de Sousa DA, Ferro JM and
Coutinho JM: Cerebral venous thrombosis. Nat Rev Neurol.
13:555–565. 2017.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Koudriavtseva T, Renna R, Plantone D and
Mainero C: Demyelinating and thrombotic diseases of the central
nervous system: Common pathogenic and triggering factors. Front
Neurol. 6(63)2015.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Vandenberghe N, Debouverie M, Anxionnat R,
Clavelou P, Bouly S and Weber M: Cerebral venous thrombosis in four
patients with multiple sclerosis. Eur J Neurol. 10:63–66.
2003.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Kwah LK and Diong J: National institutes
of health stroke scale (NIHSS). J Physiother. 60(61)2014.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Soto-Insuga V, Salvador TA, Martinez LC,
Losada del Pozo R, Moreno MR, Gonzalez CO and Catalanet JR:
Anti-myelin oligodendrocyte glycoprotein autoantibodies in optic
neuritis and venous sinus thrombosis in a girl. J Pediatr Neurol
Med. 1:1–3. 2016.
|
|
9
|
Fontana A, Greco F, Smilari P, Praticò AD,
Fiumara A, Ruggieri M and Pavone P: Anti-MOG antibody syndrome and
cerebral sinovenous thrombosis: A Cause-effect hypothesis. J
Pediatric Neurol. 19:127–131. 2021.
|
|
10
|
Malanga GA and Gangemi E: Intracranial
venous thrombosis in a patient with multiple sclerosis. A case
report and review of contraceptive alternatives in patients with
disabilities. Am J Phys Med Rehabil. 73:283–285. 1994.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Al Bunyan M and Ogunniyi A: Incidental
cerebral venous thrombosis in a patient with multiple sclerosis. J
Neurol Sci. 149:191–194. 1997.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Aidi S, Chaunu MP, Biousse V and Bousser
MG: Changing pattern of headache pointing to cerebral venous
thrombosis after lumbar puncture and intravenous high-dose
corticosteroids. Headache. 39:559–564. 1999.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Albucher JF, Vuillemin-Azaïs C, Manelfe C,
Clanet M, Guiraud-Chaumeil B and Chollet F: Cerebral
thrombophlebitis in three patients with probable multiple
sclerosis. Role of lumbar puncture or intravenous corticosteroid
treatment. Cerebrovasc Dis. 9:298–303. 1999.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Städler C, Vuadens P, Dewarrat A, Janzer
R, Uske A and Bogousslavsky J: Cerebral venous thrombosis after
lumbar puncture and intravenous steroids in two patients with
multiple sclerosis. Rev Neurol (Paris). 156:155–159.
2000.PubMed/NCBI
|
|
15
|
Gunal DI, Afsar N, Tuncer N and Aktan S: A
case of multiple sclerosis with cerebral venous thrombosis: The
role of lumbar puncture and High-dose steroids. Eur Neurol.
47:57–58. 2002.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Mouraux A, Gille M, Dorban S and Peeters
A: Cortical venous thrombosis after lumbar puncture. J Neurol.
249:1313–1315. 2002.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Kadayifçilar S, Gedik S, Eldem B, Balaban
H and Kansu T: Panuveitis associated with multiple sclerosis
complicated by cerebral venous thrombosis. Ocul Immunol Inflamm.
12:153–157. 2004.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Stolz E, Klötzsch C, Schlachetzki F and
Rahimi A: High-dose corticosteroid treatment is associated with an
increased risk of developing cerebral venous thrombosis. Eur
Neurol. 49:247–248. 2003.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Maurelli M, Bergamaschi R, Candeloro E,
Todeschini A and Micieli G: Cerebral venous thrombosis and
demyelinating diseases: Report of a case in a clinically isolated
syndrome suggestive of multiple sclerosis onset and review of the
literature. Mult Scler. 11:242–244. 2005.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Kalanie H, Harandi AA, Alidaei S, Heidari
D, Shahbeigi S and Ghorbani M: Venous thrombosis in multiple
sclerosis patients after High-dose intravenous methylprednisolone:
The preventive effect of enoxaparin. Thrombosis.
2011(785459)2011.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Presicci A, Garofoli V, Simone M, Campa
MG, Lamanna AL and Margari L: Cerebral venous thrombosis after
lumbar puncture and intravenous high dose corticosteroids: A case
report of a childhood multiple sclerosis. Brain Dev. 35:602–605.
2013.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Gazioglu S, Solmaz D and Boz C: Cerebral
venous thrombosis after high dose steroid in multiple sclerosis: A
case report. Hippokratia. 17:88–90. 2013.PubMed/NCBI
|
|
23
|
Gasparini S, Russo M, Dattola V, Ferlazzo
E and Aguglia U: Cryptogenic cerebral venous thrombosis in a
Multiple-sclerosis-patient treated with Alemtuzumab. Mult Scler
Relat Disord. 44(102246)2020.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Zhu M, Cui W, Huang W, Liu Z, Xu Z and
Huang H: Cerebral venous thrombosis after High-dose steroid in
patient with multiple sclerosis: A case report. Medicine
(Baltimore). 102(e34142)2023.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Virupakshaiah A, Moseley CE, Elicegui S,
Gerwitz LM, Spencer CM, George E, Shah M, Cree BAC, Waubant E and
Zamvil SS: Life-threatening MOG Antibody-associated hemorrhagic
ADEM with elevated CSF IL-6. Neurol Neuroimmunol Neuroinflamm.
11(e200243)2024.PubMed/NCBI View Article : Google Scholar
|
